These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 20849854)
1. Overexpression of SCYL1-BP1 stabilizes functional p53 by suppressing MDM2-mediated ubiquitination. Yan J; Di Y; Shi H; Rao H; Huo K FEBS Lett; 2010 Oct; 584(20):4319-24. PubMed ID: 20849854 [TBL] [Abstract][Full Text] [Related]
2. A newly identified Pirh2 substrate SCYL1-BP1 can bind to MDM2 and accelerate MDM2 self-ubiquitination. Yan J; Zhang D; Di Y; Shi H; Rao H; Huo K FEBS Lett; 2010 Aug; 584(15):3275-8. PubMed ID: 20598683 [TBL] [Abstract][Full Text] [Related]
3. Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice. Jung CR; Lim JH; Choi Y; Kim DG; Kang KJ; Noh SM; Im DS J Clin Invest; 2010 Dec; 120(12):4493-506. PubMed ID: 21060154 [TBL] [Abstract][Full Text] [Related]
4. HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis. Chen Y; Pan K; Wang P; Cao Z; Wang W; Wang S; Hu N; Xue J; Li H; Jiang W; Li G; Zhang X J Biol Chem; 2016 Jun; 291(24):12688-12705. PubMed ID: 27129219 [TBL] [Abstract][Full Text] [Related]
5. SCY1-like 1 binding protein 1 (SCYL1-bp1) interacts with p53-induced RING H2 protein (Pirh2) after traumatic brain injury in rats. Chen J; Zou F; Fu H; Mao H; Gong M; Ni L; Xu X; Shi J; Ke K; Cao M; Zhou F; Shi W J Mol Histol; 2013 Jun; 44(3):271-83. PubMed ID: 23479292 [TBL] [Abstract][Full Text] [Related]
6. FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53. Ochocka AM; Kampanis P; Nicol S; Allende-Vega N; Cox M; Marcar L; Milne D; Fuller-Pace F; Meek D FEBS Lett; 2009 Feb; 583(4):621-6. PubMed ID: 19166840 [TBL] [Abstract][Full Text] [Related]
7. Critical role for Daxx in regulating Mdm2. Tang J; Qu LK; Zhang J; Wang W; Michaelson JS; Degenhardt YY; El-Deiry WS; Yang X Nat Cell Biol; 2006 Aug; 8(8):855-62. PubMed ID: 16845383 [TBL] [Abstract][Full Text] [Related]
8. L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells. Ayroldi E; Petrillo MG; Bastianelli A; Marchetti MC; Ronchetti S; Nocentini G; Ricciotti L; Cannarile L; Riccardi C Cell Death Differ; 2015 Jan; 22(1):118-30. PubMed ID: 25168242 [TBL] [Abstract][Full Text] [Related]
9. Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53. Reed SM; Hagen J; Tompkins VS; Thies K; Quelle FW; Quelle DE Cell Cycle; 2014; 13(8):1288-98. PubMed ID: 24621507 [TBL] [Abstract][Full Text] [Related]
10. Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53. Chen Y; Xin H; Peng H; Shi Q; Li M; Yu J; Tian Y; Han X; Chen X; Zheng Y; Li J; Yang Z; Yang L; Hu J; Huang X; Liu Z; Huang X; Zhou H; Cui X; Li F Cancer Res; 2020 Jun; 80(11):2175-2189. PubMed ID: 32066565 [TBL] [Abstract][Full Text] [Related]
11. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation. Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825 [TBL] [Abstract][Full Text] [Related]
12. Heat shock protein gp96 decreases p53 stability by regulating Mdm2 E3 ligase activity in liver cancer. Wu B; Chu X; Feng C; Hou J; Fan H; Liu N; Li C; Kong X; Ye X; Meng S Cancer Lett; 2015 Apr; 359(2):325-34. PubMed ID: 25637791 [TBL] [Abstract][Full Text] [Related]
13. XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313. Lee MG; Han J; Jeong SI; Her NG; Lee JH; Ha TK; Kang MJ; Ryu BK; Chi SG Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15532-7. PubMed ID: 25313037 [TBL] [Abstract][Full Text] [Related]
14. Bre Enhances Osteoblastic Differentiation by Promoting the Mdm2-Mediated Degradation of p53. Jin F; Wang Y; Wang X; Wu Y; Wang X; Liu Q; Zhu Y; Liu E; Fan J; Wang Y Stem Cells; 2017 Jul; 35(7):1760-1772. PubMed ID: 28436570 [TBL] [Abstract][Full Text] [Related]
15. MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas. Song Y; Zhang L; Jiang Y; Hu T; Zhang D; Qiao Q; Wang R; Wang M; Han S Theranostics; 2019; 9(20):6019-6030. PubMed ID: 31534534 [No Abstract] [Full Text] [Related]
16. Mdm2 inhibition of p53 induces E2F1 transactivation via p21. Wunderlich M; Berberich SJ Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472 [TBL] [Abstract][Full Text] [Related]
17. Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53. Wang L; He G; Zhang P; Wang X; Jiang M; Yu L Mol Biol Rep; 2011 Jan; 38(1):229-36. PubMed ID: 20333547 [TBL] [Abstract][Full Text] [Related]
18. ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation. Ning Y; Hui N; Qing B; Zhuo Y; Sun W; Du Y; Liu S; Liu K; Zhou J Cell Death Dis; 2019 May; 10(6):414. PubMed ID: 31138778 [TBL] [Abstract][Full Text] [Related]
19. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells. Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800 [TBL] [Abstract][Full Text] [Related]
20. SCYL1-BP1 affects cell cycle arrest in human hepatocellular carcinoma cells via Cyclin F and RRM2. Wang Y; Zhi Q; Ye Q; Zhou C; Zhang L; Yan W; Wu Q; Zhang D; Li P; Huo K Anticancer Agents Med Chem; 2016; 16(4):440-6. PubMed ID: 25980818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]